Functional genomics to new drug targets

Nature Reviews Drug Discovery

Volumn 3, Issue 11, 2004, Pages 965-972

  Kramer, Richard ^a   Cohen, Dalia ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BENGAMIDE; COMPLEMENTARY RNA; CYTOSTATIC AGENT; DNA; DOUBLE STRANDED RNA; LAF 389; MORPHOLINE DERIVATIVE; OLIGONUCLEOTIDE; RIBOZYME; RNA; UNCLASSIFIED DRUG;

COMPARATIVE GENOMIC HYBRIDIZATION; DNA HYBRIDIZATION; DRUG DESIGN; DRUG MECHANISM; DRUG TARGETING; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC SCREENING; GENOME ANALYSIS; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN GENOME; NONHUMAN; PHARMACOGENOMICS; PRIORITY JOURNAL; PROTEOMICS; REVIEW; RNA INTERFERENCE;

ANIMALS; DRUG DESIGN; GENOMICS; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; PROTEOME;

EID: 8844232706     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd1552     Document Type: Review

References (77)

1. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403-410 (1990).
2. Pearson, W. R. Rapid and sensitive sequence comparison with FASTP and FASTA. Methods Enzymol. 183, 63-98 (1990).
3. Atschul, S. F. et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25, 3389-3402 (1997).
4. Eddy, S. R. HMMER: profile hidden Markov models for protein sequence analysis [online], (2001).
5. Karplus, L. e t al. What is the value added by human intervention in protein structure prediction? Proteins 45 (Suppl. 5) 86-91 (2001).
6. Smith, T. F. & Waterman, M. S. Identification of common molecular subsequences. J. Mol. Biol. 147, 195-197 (1981).
7. Lismaa, T. P. et al. G Protein-Coupled Receptors (Springer, New York, 1995).
8. Jones, C. E. et al. Expression and characterization of 5-oxo-6E, 8Z, 11Z, 14Z-eicosatetraenoic acid receptor highly expressed on human eosinophils and neutrophils. Mol. Pharmacol. 63, 471-477 (2003).
9. Tatusov, R. L., Koonin, E. V. & Lipman, D. J. A genomic perspective on protein families. Science 278, 631-637 (1997).
10. Venter, J. C. et al. The sequence of the human genome. Science 291, 1304-1351 (2001).
11. Scheel, J. et al. Yellow pages to the transcriptome. Pharmacogenomics 3, 791-807 (2002).
12. Perou, C. M. et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl Acad. Sci. USA 96, 9212-9217 (1999).
13. Golub, T. R. et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531-537 (1999).
14. Ash, A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511 (2000).
15. Scott, L et al. Prediction of central nervous system embryonal tumor outcome based on gene expression. Nature 415, 436-442 (2002).
16. Yeoh, E. J. et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic lukemia by gene expression profiling. Cancer Cell 1, 133-143 (2002).
17. Singh, D. et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1, 203-209 (2002).
18. Ross, D. T. et al. Systematic variation in gene expression in patterns in human cancer cell lines. Nature Genet. 24, 227-235 (2000).
19. Scharf, U. et al. A gene expression database for the molecular pharmacology of cancer. Nature Genet. 24, 236-244 (2000).
20. Mirnics, K., Middleton, F. A., Marquez, A., Lewis, D. A. & Levitt, P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28, 53-67 (2000).
21. Hakak, Y. et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl Acad. Sci. USA 98, 4746-4751 (2001).
22. Middleton, F. A., Mirnics, K., Pierri, J. N., Lewis, D. A. & Levitt, P. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J. Neurosci. 22, 2718-2729 (2002).
23. Vawter, P. M. et al. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr. Res. 58, 11-20 (2002).
24. Hemby, S. E. et al. Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Arch. Gen. Psychiatry 59, 631-640 (2002).
25. Buxton, F. et al. RNA profiling in the anterior cingulated in schizophrenia. (Abstracts of the 9th International Congress on Schizophrenia Research). Schizophr. Res. 60, 95 (2003).
26. Saghatelian, A., Jessani, M., Joseph, A., Humphrey, M. & Cravatt, B. F. Activity-based probes for the proteomic profiling of metalloproteases. Proc. Natl Acad. Sci. USA 101, 10000-10005 (2004).
27. Unlu, M., Morgan, M. E. & Minden, J. S. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18, 2071-2077 (1997).
28. Gygi, S. P. et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nature Biotechnol. 17, 994-999 (1999).
29. Merchant, M. & Weinberger, S. R. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 6, 1164-1177 (2000).
30. Taunton, J., Hassig, C. A. & Schreiber, S. L. A mammalian histone deacetylase related to the yeast transcripitonal regulator Rpd3p. Science 272, 408-411 (1996).
31. Petricoin, E. F. et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359, 572-577 (2002).
32. Ramachandran, N. et al. Self-assembling protein microarrays. Science 305, 86-90 (2004).
33. Towbin, H. et al. Proteomics-based target identification: bengamides as a new class of methionine aminopeptidase inhibitors. J. Biol. Chem. 278, 52964-52971 (2003).
34. Gavin, A.-C. et al. Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 415, 141-147 (2002).
35. Ho, Y. et al. Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature 415, 180-183 (2002).
36. Li, S. et al. A map of the interactome network of the metazoan C. elegans. Science 303, 540-543 (2004).
37. Giot, L. et al. A protein interaction map of Drosophila melanogaster. Science 302, 1727-1736 (2003).
38. Colland, F. et al. Functional proteomic mapping of a human signaling pathway. Genome Res. 14, 1324-1332 (2004).
39. Bouwmeester, T. et al. A physical and functional map of the human TNF-α/NF-κB signal transduction pathway. Nature Cell Biol. 6, 97-105 (2004).
40. 3 function via methoxyethoxy-modified phosphorothioated antisense oligonucleotides. Antisense Nucleic Acid Drug Dev. 11, 165-174 (2001).
41. Wahlestedt, C. et al. Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc. Natl Acad. Sci. USA 97, 5633-5638 (2000).
42. Good, L., Awasthi, S. K., Dryselius, R., Larsson, O. & Nielsen, P. E. Bactericidal antisense effects of peptide-PNA conjugates. Nature Biotechnol. 19, 360-364 (2001).
43. McCaffrey, A. P., Meuse, L., Karimi, M., Contag, C. H. & Kay, M. A. A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice. Hepatology 38, 503-508 (2003).
44. Mercatante, D., Mohler, J, & Kole, R. Cellular response to an antisense-mediated shift of bcl-x mRNA splicing and antineoplastic agents. J. Biol. Chem. 277, 49374-49382 (2002).
45. Karrars, J. G., Maier, M. A., Lu, T., Watt, A. & Manohran, M. P. Peptide nucleic acids are potent modulators of endogenous pre-mRNA splicing of the murine interleukin-5 receptor-α chain. Biochemistry 40, 7853-7859 (2001).
46. Hall, J. Unraveling the general properties of siRNAs: strength in numbers and lessons from the past. Nature Rev. Genet. 5, 552-227 (2004).
47. Kisielow, M., Kleiner, S., Magasawa, M., Faisal, A. & Nagamine, M. Isoform-specific knockdown and expression of adaptor protein shc A using small interfering RNA. Biochem. J. 363, 1-5 (2002).
48. Brummelkamp, T. R., Bernards, R. & Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553 (2002).
49. Rubinson, D. A. et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nature Genet. 33, 401-406 (2003).
50. Rushworth, S. A. et al. Inhibition of porcine DC40 expression and function by in vitro transfection with antisense oligonucleotides. Transplantation 73, 635-642 (2002).
51. Rijcken, E. et al. ICAM-1 and VCAM-1 antisense oligonucleotides attenuate in vivo leukocyte adherence and inflammation in rat inflammatory bowel disease. Gut 51, 529-535 (2002).
52. 3 receptor. Nucleic Acids Res. 31, 2117-2126 (2003).
53. 3 receptor subunit in rat sensory neurons reveals a significant role in chronic neuropathic and inflammatory pain. J. Neurosci. 22, 8139-8147 (2002).
54. Dorn, G. et al. siRNA relieves chronic neuropathic pain. Nucleic Acids Res. 32, e49 (2004).
55. 2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration. Br. J. Pharmacol. 140, 1381-1388 (2003).
56. Strausberg, R. L. et al. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl Acad. Sci. USA 99, 16899-16903 (2002).
57. Walhout, A. J. et al. GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes. Methods Enzymol. 328, 575-592 (2000).
58. Simpson, J. C., Wellenreuther, R., Poustka, A., Pepperkok, R. & Wiemann, S. Systematic subcellular localization of novel proteins identified by large scale cDNA sequencing. EMBO Rep. 3, 287-292 (2003).
59. Michiels, F. et al. Arrayed adenoviral expression libraries for functional screening, Nature Biotechnol. 20, 1154-1157 (2002).
60. Matsuda, A. et al. Large-scale identification and characterzation of human genes that activate NF-κB and MAPK signaling pathways. Oncogene 22, 2307-2318 (2003).
61. Fiscella, M. et al. TIP, a T-cell factor identified using high-throughput screening increases survival in a graft-versus-host disease model. Nature Biotechnol. 21, 302-307 (2003).
62. Chen, C. et al. An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis. Nature Biotechnol. 21, 294-301 (2003).
63. Iourgenko, V. et al. Identification of family of cAMP response element-binding protein co-activators by genome-scale functional analysis in mammalian cells. Proc. Natl Acad. Sci. USA 100, 12147-12152 (2003).
64. Chanda, S. K. et al. Genome-scale functional profiling of the mammalian AP-1 signaling pathway. Proc. Natl Acad. Sci. USA 100, 12153-12158 (2003).
65. Paddison, P. J. et al. A resource for large-scale RNA-interference-based screens in mammals. Nature 428, 427-431 (2004).
66. Berns, K. et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428 431-437 (2004).
67. Li, H. & Garza, D. in Model Organisms in Drug Discovery (eds Carroll, P. M. & Fitzgerald, K.) 81-117 (Wiley, Chichester, 2003).
68. Konsolaki, M. & Cohen, D. Targets for Alzheimer's disease: lessons learnt from flies. Drug Discov. Today 3, 64-70 (2004).
69. Langheinrich, U. Zebrafish: a new model on the pharmaceutical catwalk. Bioessays 25, 904-912 (2003).
70. Milan, D. J., Peterson, T. A., Ruskin, J. N., Peterson, R. T. & MacRae, C. A. Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation 107, 1355-1358 (2003 ).
71. Fermini, B. & Fossa, A. A. The impact of drug-induced QT interval prolongation on drug discovery and development. Nature Rev. Drug Discov. 2, 439-447 (2003).
72. Chan, J., Bayliss, P. E., Wood, J. M. & Roberts, T. M. Dissection of angiogenic signaling in zebrafish using a chemical genetic approach. Cancer Cell 1, 257-267 (2002).
73. Farber, S. A. et al. Genetic analysis of digestive physiology using fluorescent phospholipids reporters. Science 292, 1385-1388 (2001).
74. Darland, T. & Dowling, J. E. Behavioral screening for cocaine sensitivity in mutagenized zebrafish. Proc. Natl Acad. Sci. USA 98, 11691-11696 (2001).
75. Lockwood, B., Bjerke, S., Kobayashi, K. & Guo, S. Acute effects of alcohol on larval zebrafish: a genetic systems for large-scale screening. Pharmaco, Biochem. Behav. 77, 647-654 (2004).
76. Peterson, R. T. et al. Chemical suppression of a genetic mutation in a zebrafish model of aortic coarotation. Nature Biotechnol. 22, 595-599 (2004).
77. Finelli, A., Kelkar, A., Song, H., Yang, H. & Konsolaki, M. A model for Alzheimer's Aβ42-induced toxicity in Drosophila melanogaster. Mol. Cell. Neurosci. 26, 365-375 (2004).